Sort
51,593 grants matching “hepatitis”
ADULT AIDS CLINICAL TRIALS UNIT
$1,227,954University Of Pittsburgh At Pittsburgh · U01 · FY2001 · AI
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
$1,227,827Sallie R. Permar · Duke University · P01 · FY2020 · AI
Diagnosis, Pathophysiology And Molecular Biology Of Pheochromocytoma
$1,227,520Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Cornell Clinical Trials Unit
$1,227,503Roy M Gulick · Weill Medical Coll Of Cornell Univ · U01 · FY2011 · AI
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
$1,226,902Shruti H Mehta · Johns Hopkins University · R01 · FY2015 · DA
Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis
$1,225,995Ramon Bataller · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AA
Immunology of Acute and Chronic Viral Hepatitis
$1,225,798Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Vanderbilt HIV Clinical Trials Unit
$1,224,853David W Haas · Vanderbilt University Medical Center · UM1 · FY2016 · AI
Liver Pathobiology and Gene Theraphy Research Core Center
$1,224,831David A Shafritz · Albert Einstein College Of Medicine · P30 · FY2011 · DK
HIV-1 Preintegration Trafficking and Nuclear Localization
$1,224,434Alan N. Engelman · Dana-Farber Cancer Inst · R01 · FY2025 · AI
Hereditary Causes of Nephrolithaisis and Kidney Failure
$1,224,428Dawn S Milliner · Mayo Clinic Rochester · U54 · FY2012 · DK
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$1,224,338Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA
Washington Metropolitan Women's Interagency HIV Study
$1,223,446Mary A Young · Georgetown University · U01 · FY2010 · AI
Treatment for alcoholic liver disease
$1,223,250Bert J. W. M. Oehlen · Angion Biomedica Corporation · R44 · FY2012 · AA
Hereditary Causes of Nephrolithaisis and Kidney Failure
$1,222,963Dawn S Milliner · Mayo Clinic Rochester · U54 · FY2013 · DK
Multidisciplinary Studies of Lymphoma
$1,222,206Patricia Hartge · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Metabolic effects and mechanisms for heart failure in South Asians
$1,221,536Alka M Kanaya · University Of California, San Francisco · R01 · FY2024 · HL
Silvio O. Conte Digestive Diseases Research Core Centers
$1,221,142Michael H Nathanson · Yale University · P30 · FY2011 · DK
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
$1,221,014Serena Patricia Koenig · Brigham And Women'S Hospital · U01 · FY2022 · AI
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,220,843Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation
$1,219,852Siu Kit Lam · Immunophotonics, Inc. · R44 · FY2023 · CA
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
$1,219,675Gerald I Shulman · Yale University · R24 · FY2013 · DK
SILVIO O.CONTE DIGESTIVE DISEASES RESEARCH CORE CENTERS
$1,219,265Yale University · P30 · FY2005 · DK
SILVIO O.CONTE DIGESTIVE DISEASES RESEARCH CORE CENTERS
$1,219,265Yale University · P30 · FY2004 · DK
Stellenbosch University Clinical Trials Unit
$1,218,433Anneke Catharina Hesseling · Stellenbosch University · UM1 · FY2023 · AI